Familial adenomatous polyposis

Search Trials
Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA
Status:
Completed
Last Changed:
Aug 22, 2014
First Changed:
Aug 2, 2007
Disease(s):
Familial Adenomatous Polyposis Coli
Intervention(s):
Eicosapentanoic Acid (EPA)EndoscopyBiopsies takenPlacebo
Sirolimus and Familial Adenomatous Polyposis (FAP)
Status:
Completed
Last Changed:
Jan 28, 2019
First Changed:
Mar 30, 2017
Disease(s):
Adenomatous Polyposis Coli
Intervention(s):
Sirolimus
A Study of Guselkumab in Participants With Familial Adenomatous Polyposis
Status:
Recruiting
Last Changed:
Jan 4, 2019
First Changed:
Aug 28, 2018
Disease(s):
Adenomatous Polyposis Coli
Intervention(s):
GuselkumabPlacebo
Molecular Fluorescence Endoscopy in Patients With Familial Adenomatous Polyposis, Using Bevacizumab-IRDye800CW
Status:
Completed
Last Changed:
Jan 11, 2016
First Changed:
Apr 14, 2014
Disease(s):
Adenomatous Polyposis Coli
Intervention(s):
Bevacizumab-IRDye800CWNear infrared fluorescence endoscopy platform
Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients
Status:
Terminated
Last Changed:
Mar 9, 2010
First Changed:
Sep 9, 2005
Disease(s):
Familial Adenomatous Polyposis (FAP)
Intervention(s):
CelecoxibRoutine Medical Care

Connect. Empower. Inspire.